Literature DB >> 12225494

One-year outcome in first episode psychosis patients in the Swedish Parachute project.

J Cullberg1, S Levander, R Holmqvist, M Mattsson, I-M Wieselgren.   

Abstract

OBJECTIVE: Implementing a system designed to treat first episode psychotic (FEP) patients.
METHOD: Every FEP patient (n=253) from a catchment area of 1.5 million inhabitants were asked to participate in this 5-year project. One historical (n=71) and one prospective (n=64) FEP group were used for comparisons.
RESULTS: A total of 175 patients (69%) were followed up through the first year of treatment. Global Assessment of Functioning (GAF) values were significantly higher than in the historical comparison group but similar to the prospective group. Psychiatric in-patient care was lower as was prescription of neuroleptic medication. Satisfaction with care was generally high in the Parachute group. Access to a small overnight crisis home was associated with higher GAF.
CONCLUSION: It is possible to successfully treat FEP patients with fewer in-patient days and less neuroleptic medication than is usually recommended, when combined with intensive psychosocial treatment and support.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225494     DOI: 10.1034/j.1600-0447.2002.02376.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  25 in total

1.  Soteria Berne: an innovative milieu therapeutic approach to acute schizophrenia based on the concept of affect-logic.

Authors:  Luc Ciompi; Holger Hoffmann
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

Review 2.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 3.  Review of the operational definition for first-episode psychosis.

Authors:  Nicholas J K Breitborde; Vinod H Srihari; Scott W Woods
Journal:  Early Interv Psychiatry       Date:  2009-11       Impact factor: 2.732

4.  Treatment of patients with first-episode psychosis: two-year outcome data from the Danish National Schizophrenia Project.

Authors:  Bent Rosenbaum; Kristian Valbak; Susanne Harder; Per Knudsen; Anne Køster; Matilde Lajer; Anne Lindhardt; Gerda Winther; Lone Petersen; Per Jørgensen; Merete Nordentoft; Anne Helms Andreasen
Journal:  World Psychiatry       Date:  2006-06       Impact factor: 49.548

5.  Integrated treatment and implications for off-medication periods.

Authors:  Johan Cullberg
Journal:  Schizophr Bull       Date:  2006-02-03       Impact factor: 9.306

6.  Gender differences in the prediction of 5-year outcome in first episode psychosis.

Authors:  Maria Mattsson; Lena Flyckt; Gunnar Edman; Håkan Nyman; Johan Cullberg; Yvonne Forsell
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

7.  Psychometric evaluation of the Danish and Swedish Satisfaction with Life Scale in first episode psychosis patients.

Authors:  Jacek Hochwälder; Maria Mattsson; Ragnhild Holmqvist; Johan Cullberg; Bent Rosenbaum
Journal:  Qual Life Res       Date:  2012-05-15       Impact factor: 4.147

Review 8.  Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.

Authors:  Mario Alvarez-Jiménez; Alexandra G Parker; Sarah E Hetrick; Patrick D McGorry; John F Gleeson
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

Review 9.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.

Authors:  Tim Calton; Michael Ferriter; Nick Huband; Helen Spandler
Journal:  Schizophr Bull       Date:  2007-06-14       Impact factor: 9.306

10.  The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis.

Authors:  Tom K J Craig; Philippa Garety; Paddy Power; Nikola Rahaman; Susannah Colbert; Miriam Fornells-Ambrojo; Graham Dunn
Journal:  BMJ       Date:  2004-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.